Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Lung injury associated with bucillamine therapy].
Negishi M, Kaga S, Kasama T, Hashimoto M, Fukushima T, Yamagata N, Tabata M, Kobayashi K, Ide H, Takahashi T. Negishi M, et al. Among authors: fukushima t. Ryumachi. 1992 Apr;32(2):135-9. Ryumachi. 1992. PMID: 1595005 Japanese.
Antibodies to interleukin 2 in sera of autoimmune-prone mice.
Tabata M, Kobayashi K, Kaga S, Hashimoto M, Kasama T, Fukushima T, Yoshida K, Yamagata N, Sekine F, Ohno I, et al. Tabata M, et al. Among authors: fukushima t. Scand J Rheumatol. 1990;19(3):183-8. doi: 10.3109/03009749009095041. Scand J Rheumatol. 1990. PMID: 2359996
Production of interleukin 1-like factor from human peripheral blood monocytes and polymorphonuclear leukocytes by superoxide anion: the role of interleukin 1 and reactive oxygen species in inflamed sites.
Kasama T, Kobayashi K, Fukushima T, Tabata M, Ohno I, Negishi M, Ide H, Takahashi T, Niwa Y. Kasama T, et al. Among authors: fukushima t. Clin Immunol Immunopathol. 1989 Dec;53(3):439-48. doi: 10.1016/0090-1229(89)90006-8. Clin Immunol Immunopathol. 1989. PMID: 2553311
[Studies on the results of anti-toxoplasma enzyme-linked immunosorbent assay and false positive reactions in patients with progressive systemic sclerosis, rheumatoid arthritis and systemic lupus erythematosus].
Sekine F, Fukushima T, Tabata Y, Satoh H, Ohno I, Kobayashi K, Ohseto Y, Negishi M, Ide H, Takahashi T. Sekine F, et al. Among authors: fukushima t. Nihon Naika Gakkai Zasshi. 1985 Jan;74(1):7-12. doi: 10.2169/naika.74.7. Nihon Naika Gakkai Zasshi. 1985. PMID: 3998581 Japanese. No abstract available.
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.
Tauchi T, Kizaki M, Okamoto S, Tanaka H, Tanimoto M, Inokuchi K, Murayama T, Saburi Y, Hino M, Tsudo M, Shimomura T, Isobe Y, Oshimi K, Dan K, Ohyashiki K, Ikeda Y; TARGET Investigators. Tauchi T, et al. Leuk Res. 2011 May;35(5):585-90. doi: 10.1016/j.leukres.2010.10.027. Epub 2010 Dec 10. Leuk Res. 2011. PMID: 21145591
2,550 results